ACOR and OBLN hit 52 week lows on Friday. ACOR: Acorda Therapeutics developes therapies for neurological disorders..3.10 OBLN: Obalon Therapeutics developes devices for the obese..3.24 Accumulate FCEL...30-.33...NAKD...07-.075..PNTV...018-.02